KEPIVANCE

NDC 66658-113 · Swedish Orphan Biovitrum AB (publ)

Generic namepalifermin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)PALIFERMIN

Strength5.16 mg/1.2mL

Pharmacologic classFibroblast Growth Factor 7 [CS], Increased Epithelial Proliferation [PE], Mucocutaneous Epithelial Cell Growth Factor [EPC]

Marketing categoryBLA

Packages

66658-113-03 — 3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1 VIAL, SINGLE-USE (66658-113-01)

J2425 — Injection, palifermin, 50 micrograms Medicare Part B payment limit (ASP + 6%): $38.69

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.